These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28517962)

  • 1. Inhibition of the Continuum of Radiation-Induced Normal Tissue Injury by a Redox-Active Mn Porphyrin.
    Birer SR; Lee CT; Choudhury KR; Young KH; Spasojevic I; Batinic-Haberle I; Crapo JD; Dewhirst MW; Ashcraft KA
    Radiat Res; 2017 Jul; 188(1):94-104. PubMed ID: 28517962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.
    Ashcraft KA; Boss MK; Tovmasyan A; Roy Choudhury K; Fontanella AN; Young KH; Palmer GM; Birer SR; Landon CD; Park W; Das SK; Weitner T; Sheng H; Warner DS; Brizel DM; Spasojevic I; Batinic-Haberle I; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):892-900. PubMed ID: 26530759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation.
    Toshkov IA; Gleiberman AS; Mett VL; Hutson AD; Singh AK; Gudkov AV; Burdelya LG
    Radiat Res; 2017 May; 187(5):570-580. PubMed ID: 28323577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP
    Leu D; Spasojevic I; Nguyen H; Deng B; Tovmasyan A; Weitner T; Sampaio RS; Batinic-Haberle I; Huang TT
    Redox Biol; 2017 Aug; 12():864-871. PubMed ID: 28454069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
    Brizel DM; Wasserman TH; Henke M; Strnad V; Rudat V; Monnier A; Eschwege F; Zhang J; Russell L; Oster W; Sauer R
    J Clin Oncol; 2000 Oct; 18(19):3339-45. PubMed ID: 11013273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preclinical model to investigate normal tissue damage following fractionated radiotherapy to the head and neck.
    Juvkam IS; Zlygosteva O; Arous D; Galtung HK; Malinen E; Søland TM; Edin NJ
    J Radiat Res; 2023 Jan; 64(1):44-52. PubMed ID: 36253091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of radiation injuries to the salivary glands after treatment of head and neck cancers].
    Urban A; Miszczyk L; Maciejewski B
    Otolaryngol Pol; 2005; 59(1):21-5. PubMed ID: 15915914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland sparing in the treatment of head and neck cancer.
    Scrimger R
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
    Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Z-100 as radiation mucositis protector in head and neck tumor management].
    Miyashita T; Morita S; Shibuya H; Takeda M; Horiuchi J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):295-7. PubMed ID: 8177707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.
    Boss MK; Dewhirst MW; Sampaio RS; Bennett A; Tovmasyan A; Berman KG; Beaven AW; Rizzieri DA; Batinic-Haberle I; Hauck ML; Spasojevic I
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):421-431. PubMed ID: 28685347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.
    Veerasarn V; Phromratanapongse P; Suntornpong N; Lorvidhaya V; Sukthomya V; Chitapanarux I; Tesavibul C; Swangsilpa T; Khorprasert C; Shotelersuk K; Kongthanarat Y; Panichevaluk A; Chiewvit S; Pusuwan P; Aekmahachai M; Ratchadara S; Sirilipoche S; Saengsuda Y
    J Med Assoc Thai; 2006 Dec; 89(12):2056-67. PubMed ID: 17214057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current ideas to reduce or salvage radiation damage to salivary glands.
    Vissink A; van Luijk P; Langendijk JA; Coppes RP
    Oral Dis; 2015 Jan; 21(1):e1-10. PubMed ID: 24581290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury.
    Rabbani ZN; Batinic-Haberle I; Anscher MS; Huang J; Day BJ; Alexander E; Dewhirst MW; Vujaskovic Z
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):573-80. PubMed ID: 17236973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands.
    Pimentel MJ; Filho MM; Araújo M; Gomes DQ; DA Costa LJ
    Anticancer Res; 2014 Apr; 34(4):1993-9. PubMed ID: 24692737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis.
    Epperly MW; Carpenter M; Agarwal A; Mitra P; Nie S; Greenberger JS
    In Vivo; 2004; 18(4):401-10. PubMed ID: 15369176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.